Signifier Medical Technologies Raises $35M In Series D
The UK-based company said it will use the new funding to advance commercialization of its daytime treatment for mild sleep apnea and snoring.
The UK-based company said it will use the new funding to advance commercialization of its daytime treatment for mild sleep apnea and snoring.